News & Press Releases

Life Sciences Litigation Chair and Patent Litigation Co-chair Sige Gutman, recently spoke with Generics Bulletin about the impact of biosimilar streamlining on development, competition, and IP strategy.

Joshua N. Rudin, Co-chair of Mintz’s Digital Infrastructure Practice, was quoted in an article by Bisnow exploring how the surge in hyperscale data center development may be giving way to increased demand for smaller, strategically located facilities driven by AI inference workloads and evolving infrastructure needs.

Member and chair of the crisis management and strategic response practice Erek L. Barron recently shared insights in a Law360 expert analysis on Maryland’s rapidly evolving data privacy landscape, highlighting how the state’s dual-statute framework places it at the forefront of privacy regulation.

Sige Gutman, Chair of Mintz’s Life Sciences Litigation Practice, was quoted in an Endpoints News article examining Supreme Court oral arguments on the limits of “skinny label” drug marketing and potential patent infringement liability for generic manufacturers.

Member Rachel Alexander was quoted in a Bloomberg Law article examining how recent federal appellate court rulings are putting state pharmacy laws under increased scrutiny, particularly “any willing pharmacy” requirements affecting pharmacy benefit managers and ERISA regulated health plans.

Steven Shparber, Co-chair of Mintz’s Digital Infrastructure Practice, recently spoke with Data Center Knowledge about the growing use of behind-the-meter power by data center operators as they face grid delays and rising AI-driven demand.